Senseonics 报告的亏损大于预期，但高管们购买了股票。 Senseonics reported a bigger loss than expected but saw execs buy shares.

医疗技术公司Sensenics(NYSE:SENS)报告的季度损失大于预期,EPS为0.12美元,而预期为0.03美元。 Medical tech firm Senseonics (NYSE:SENS) reported a larger-than-expected quarterly loss, with EPS at ($0.12) versus an expected ($0.03). 该公司更新了2025财政年度指南,并看到首席执行官Timothy T. Goodnow和CFO Frederick T. Sullivan购买了股票。 The company updated its FY 2025 guidance and saw CEO Timothy T. Goodnow and CFO Frederick T. Sullivan buy shares. 感官系统为糖尿病患者开发连续的葡萄糖监测系统,市场上限为5.1793亿美元。 Senseonics develops continuous glucose monitoring systems for diabetes patients and has a market cap of $517.93 million.